DaVita said it reported consolidated revenues of $3.071 billion, operating income of $484 million (adjusted operating income of $463 million), and diluted earnings per share of $2.65 (adjusted $2.38) for the quarter ended March 31, 2024.

1. 01

   DaVita said it reported consolidated revenues of $3.071 billion, operating income of $484 million (adjusted operating income of $463 million), and diluted earnings per share of $2.65 (adjusted $2.38) for the quarter ended March 31, 2024.

2. 02

   The company said operating cash flow was $(135) million and free cash flow was $(327) million for Q1. The company said the Change Healthcare outage delayed claims processing, which increased its days sales outstanding and weighed on operating cash flow.

3. 03

   The company said it repurchased 2.1 million shares of its common stock in Q1 2024 at an average price paid of $112.76 per share, for a total of $240 million.

4. 04

   The company gave full-year 2024 outlook for adjusted operating income of $1,875 million to $1,975 million, adjusted diluted earnings per share of $9.00 to $9.80, and free cash flow of $900 million to $1,150 million. The company said the low end of its prior adjusted operating income outlook was $1,825 million, and the low end of its prior adjusted earnings per share outlook was $8.70.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.